Feb 25 (Reuters) - Henry Schein (HSIC.O), opens new tab forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid ...

Here are three reasons why there are better opportunities than HSIC and a stock we'd rather own. With a vast inventory of ...

These solutions also support dental laboratories ... with a selection of more than 300,000 branded products and Henry Schein corporate brand products in the Company’s distribution centers.

Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and ...

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and ...

R. Weinstein, which was established in 1984, provides vaccines, medical-surgical products, and equipment to local health care facilities. Henry Schein, which serves dental and medical offices ...

At its core, Henry Schein is a firm that's dedicated ... marketing, and sales, of dental implant and biomaterial products. It also involves the sale of other health care related products such ...

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and ...